SAN GERONIMO, Calif., Jan. 5, 2012 (GLOBE NEWSWIRE) -- Virogen, Inc. (OTC:VRNI), a holding company specializing in data security and encryption technology, today announced that it has initiated the application process to the London Stock Exchange plc for a listing on the Alternative Investment Market (AIM).
It is expected that the listing and trading on AIM will take place on or about March 31, 2012. Virogen will announce the symbol for trading on AIM prior to commencement of trading. The Company's common stock will continue to trade in the U.S. on the OTC markets under the trading symbol VRNI. There will be no capital raising associated with the listing.
AIM (Alternative Investment Market) is the London Stock Exchange's international market for smaller emerging companies. It is the most successful growth market in the world, and since its launch in 1995, more than 3,000 companies from around the world have listed on AIM.
Virogen's Chief Executive Officer, Paul Hogan, commented, "We look forward to the listing of our common stock on London's AIM. This is a strategic move that is in line with our plans to expand our clientele and services to various international markets and represents a positive milestone for the company."
About Virogen, Inc.
Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
Forward-Looking Statements:
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.